BRAF and thyroid cancer: For example, the transgenic mice model with selective activation of the BRAFV600E mutation in the thyroid gland, which leads to thyroid cancer development and progression to more aggressive histotypes (6,7), has shown that cancer initiation may be enhanced by TSH signaling and that BRAF-induced thyroid cancer is addicted to MAPK signaling (8,9).